Tag: Cancer biology

Cdc25

Cdc25 phosphatases activate CDKs to drive both the G1–S and G2–M transitions. By removing inhibitory phosphates from CDK1 and CDK2, Cdc25 triggers DNA replication and mitotic entry. Checkpoint kinases such as Chk1 inhibit Cdc25 during DNA damage, while Cdc25 overexpression promotes genomic instability and contributes to tumour progression.

Cdh1

Cdh1 is a major activator of the APC/C complex, responsible for mitotic exit, G1 maintenance and replication licensing. By degrading Cyclin B, Aurora A, Plk1 and Geminin, Cdh1 prevents premature S‑phase entry and maintains genomic stability. Its dysregulation contributes to replication stress, chromosomal instability and cancer development.

Cdc20

Cdc20 is a key activator of the APC/C complex, initiating the metaphase‑to‑anaphase transition by promoting securin and Cyclin B degradation. Regulated by checkpoint proteins such as Mad2 and BubR1, Cdc20 safeguards chromosome segregation, while its dysregulation contributes to aneuploidy and cancer progression.

Cancer

Cancer is a multifaceted disease caused by the uncontrolled growth of abnormal cells. It develops through genetic and epigenetic alterations, environmental exposures, and interactions within the tumour microenvironment. Understanding these processes is essential for improving prevention, diagnosis, and treatment.

Synaptonemal Complex

The synaptonemal complex is a meiosis‑specific protein structure essential for homologous chromosome pairing, recombination, and fertility. Its disruption leads to meiotic arrest, aneuploidy, and reproductive disorders.

TEX11

Further reading: Sha Y., et al., 2018. A novel TEX11 mutation induces azoospermia: a case report of infertile brothers and…

Cdc25

Cdc25 phosphatases activate CDKs to drive both the G1–S and G2–M transitions. By removing inhibitory phosphates from CDK1 and CDK2, Cdc25 triggers DNA replication and mitotic entry. Checkpoint kinases such as Chk1 inhibit Cdc25 during DNA damage, while Cdc25 overexpression promotes genomic instability and contributes to tumour progression.

Cdh1

Cdh1 is a major activator of the APC/C complex, responsible for mitotic exit, G1 maintenance and replication licensing. By degrading Cyclin B, Aurora A, Plk1 and Geminin, Cdh1 prevents premature S‑phase entry and maintains genomic stability. Its dysregulation contributes to replication stress, chromosomal instability and cancer development.

Cdc20

Cdc20 is a key activator of the APC/C complex, initiating the metaphase‑to‑anaphase transition by promoting securin and Cyclin B degradation. Regulated by checkpoint proteins such as Mad2 and BubR1, Cdc20 safeguards chromosome segregation, while its dysregulation contributes to aneuploidy and cancer progression.

Cancer

Cancer is a multifaceted disease caused by the uncontrolled growth of abnormal cells. It develops through genetic and epigenetic alterations, environmental exposures, and interactions within the tumour microenvironment. Understanding these processes is essential for improving prevention, diagnosis, and treatment.

Synaptonemal Complex

The synaptonemal complex is a meiosis‑specific protein structure essential for homologous chromosome pairing, recombination, and fertility. Its disruption leads to meiotic arrest, aneuploidy, and reproductive disorders.

TEX11

Further reading: Sha Y., et al., 2018. A novel TEX11 mutation induces azoospermia: a case report of infertile brothers and…